Healthcare / Medical Care FacilitiesHKSE
$0.51
-0.02 (-3.77%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $114.1M · quality 65.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
14/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$249M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-26.9%
↓Gross Margin
29.3%
↓Debt/Equity
0.39
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-1.9%
FCF CAGR
-50.0%
FCF margin
1.4%
FCF / Net income
-0.07x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $600.1M · net income $-115.3M · FCF $8.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $600.1M | $600.1M | $846.5M | $933.1M | $636.5M |
| Net Income | $-115.3M | $-115.3M | $47.4M | $84.2M | $-297.7M |
| EBITDA | $-20.3M | $-20.3M | $200.8M | $234.2M | $-209.5M |
| EPS | — | — | 0.10 | 0.17 | -0.62 |
| Gross Margin | 29.3% | 29.3% | 40.8% | 43.6% | 31.8% |
| Operating Margin | -1.9% | -1.9% | 17.6% | 22.0% | 0.6% |
| Net Margin | -19.2% | -19.2% | 5.6% | 9.0% | -46.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.39 | 0.39 | 0.34 | 0.39 | 0.50 |
| Current Ratio | 1.28 | 1.28 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $8.3M | $8.3M | $114.1M | $148.2M | $66.2M |
| Returns | |||||
| ROE | -26.9% | -26.9% | 8.6% | 16.1% | -67.9% |
| Valuation | |||||
| P/E | — | — | 10.00 | 4.53 | — |
| EV/EBITDA | — | — | 1.57 | 1.17 | — |
| P/B | 0.58 | 0.58 | 0.87 | 0.71 | 0.53 |
| Growth & Yield | |||||
| Revenue Growth | -29.1% | -29.1% | -9.3% | 46.6% | — |
| EPS Growth | — | — | -41.2% | 127.4% | — |
| Dividend Yield | 4.3% | 4.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-53.6%
Start / end P/E
n/dx → n/dx
EPS bridge
0.10 → n/d
Residual
-57.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.